ZOFRASET ondansetron (as hydrochloride dihydrate) 4 mg/2 mL solution for injection pre-filled syringe

País: Australia

Idioma: inglés

Fuente: Department of Health (Therapeutic Goods Administration)

Ingredientes activos:

ondansetron hydrochloride dihydrate, Quantity: 4.99 mg (Equivalent: ondansetron, Qty 4 mg)

Disponible desde:

Accord Healthcare Pty Ltd

formulario farmacéutico:

Injection, solution

Composición:

Excipient Ingredients: citric acid monohydrate; sodium citrate dihydrate; sodium hydroxide; water for injections; hydrochloric acid; sodium chloride

Vía de administración:

Intramuscular, Intravenous

Unidades en paquete:

Pack of 1 pre-filled syringe

tipo de receta:

(S4) Prescription Only Medicine

indicaciones terapéuticas:

Ondansetron injection is indicated ? For the prevention and treatment of nausea and vomiting induced by cytotoxic therapy and radiotherapy. ? For the prevention and treatment of post-operative nausea and vomiting.

Resumen del producto:

Visual Identification: Clear, colourless solution in an amber glass pre-filled syringe; Container Type: Syringe; Container Material: Glass Type I Coloured; Container Life Time: 24 Months; Container Temperature: Store below 25 degrees Celsius; Container Closure: Neither child resistant closure nor restricted flow insert

Estado de Autorización:

Registered

Fecha de autorización:

2020-11-09